Lv6
1992 积分 2023-08-20 加入
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
8天前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
12天前
已完结
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
14天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
17天前
已完结
Efficacy of 24-weekly vs 12-weekly decapeptyl SR treatment in central precocious puberty: a UK multicentre retrospective cohort study
18天前
已关闭
Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls
18天前
已完结
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
19天前
已完结
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
20天前
已完结
AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis
20天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
30天前
已完结
皖公网安备34019202002308
